News
Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca's fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...
The clinical, cardiovascular and neuroendocrine profile of ampreloxetine showed target engagement of residual peripheral autonomic neurons and a sustained standing blood pressure effect, which is ...
Colt Data Centre Services (Colt DCS), global provider of hyperscale and large enterprise data centre facilities, today ...
The Westlake Fishing Derby takes place from 9 a.m. to noon May 10 at the Recreation Center Pond, 28955 Hilliard Blvd. The ...
Madison Investments, an investment advisor, released its “Madison Large Cap Fund” first-quarter 2025 investor letter. A copy ...
Rockwell Automation, Inc. ( NYSE: ROK) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Aijana Zellner - Head of IR and Market Strategy Blake Moret - Chairman and CEO Christian Rothe - CFO ...
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...
7d
Futurism on MSNScammers Stole the Website for Emerson College's Student Radio Station and Started Running It as a Zombie AI FarmEarlier this month, student leaders at Emerson College's student radio station, WECB, received an urgent email from a student ...
Part 2a is designed to confirm the primary dose-of-interest with a target enrollment of approximately 30 patients at each of two dose levels: 400mg QD 5:2 and 300mg QD 5:2 (intermittent daily dosing ...
A trademark is worth obtaining if you want your recognisable symbols, phrases, marks or sounds to be exclusively used by your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results